Ams R&d - Wavera Technology

Wavera® is an innovative pump technology developed and marketed by the French company AMS R&D. Bio-inspired, the Wavera® technology consists in the undulation of a membrane, like the fin of a fish, allowing the propulsion of all types of fluids (pure or charged) for pumps, ventilators and compressors. The main benefits of this breakthough technology are : high energy efficiency, electric power supply, continuous flow, very low shear stress, self-priming, allowing particles, totally sealed. AMS R&D is implementing its Wavera® technology in high-potential markets : health, energy, environment, transport, home appliance and consumer STRATEGIC OPPORTUNITY (2018) FOR PUMP MANUFACTURERS Want to reach new markets and new customers? Incorporate a breakthrough technology with multiple benefits into your catalog! AMS R&D is looking for pump manufacturers for licensing the innovative Wavera® technology for specific applications and territories. Please contact Erik GUILLEMIN, President of AMS R&D, for more information : erik.guillemin@wavera.tech START-UP MEDTECH : CORWAVE The CorWave Joint Venture, a true MedTech nugget, was founded to apply Wavera® technology to the cardiac application LVAD (Left Ventricular Assist Device). AMS R&D owns the Wavera® and French Pump® brands.